Literature DB >> 6174690

Active uptake of substance P carboxy-terminal heptapeptide (5-11) into rat brain and rabbit spinal cord slices.

Y Nakata, Y Kusaka, H Yajima, T Segawa.   

Abstract

We previously reported that nerve terminals and glial cells lack an active uptake system capable of terminating transmitter action of substance P (SP). In the present study, we demonstrated the existence of an active uptake system for SP carboxy-terminal heptapeptide, (5-11)SP. When the slices from either rat brain or rabbit spinal cord were incubated with [3H](5-11)SP, the uptake of (5-11)SP into slices was observed. The uptake system has the properties of an active transport mechanism: it is dependent on temperature and sensitive to hypoosmotic treatment and is inhibited by ouabain and dinitrophenol (DNP). In the brain, (5-11)SP was accumulated by means of a high-affinity and a low-affinity uptake system. The Km and the Vmax values for the high-affinity system were 4.20 x 10(-8) M and 7.59 fmol/10 mg wet weight/min, respectively, whereas these values for the low-affinity system were 1.00 x 10(-6) M and 100 fmol/10 mg wet weight/min, respectively. In the spinal cord, there was only one uptake system, with a Km value of 2.16 x 10(-7) M and Vmax value of 26.2 fmol/10 mg wet weight/min. These results suggest that when SP is released from nerve terminals, it is hydrolysed into (5-11)SP before or after acting as a neurotransmitter, which is in turn accumulated into nerve terminals. Therefore, the uptake system may represent a possible mechanism for the inactivation of SP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174690     DOI: 10.1111/j.1471-4159.1981.tb06323.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  How peptidergic neurons cope with variation in physiological stimulation.

Authors:  I G Morgan; I W Chubb
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

2.  Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig--evidence for extraneuronal cleavage of neuropeptide K to neurokinin A.

Authors:  C R Martling; E Theodorsson-Norheim; I Norheim; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

3.  Substance P in Solution: Trans-to-Cis Configurational Changes of Penultimate Prolines Initiate Non-enzymatic Peptide Bond Cleavages.

Authors:  Christopher R Conant; Daniel R Fuller; Tarick J El-Baba; Zhichao Zhang; David H Russell; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-12       Impact factor: 3.109

4.  Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma.

Authors:  L A Frohman; T R Downs; E P Heimer; A M Felix
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 5.  Comparative aspects of structure and action of molluscan neuropeptides.

Authors:  Y Muneoka; M Kobayashi
Journal:  Experientia       Date:  1992-05-15

Review 6.  Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity.

Authors:  J P Huston; R U Hasenöhrl; F Boix; P Gerhardt; R K Schwarting
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Synthesis and preliminary evaluation of a new (99m)tc labeled substance p analogue as a potential tumor imaging agent.

Authors:  Saeed Mozaffari; Mostafa Erfani; Davood Beiki; Fariba Johari Daha; Farzad Kobarfard; Saeed Balalaie; Babak Fallahi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.